Method and apparatus for implantable cardiac lead integrity analysis

• US 10,118,031 B2
• Filed: 03/11/2014
• Issued: 11/06/2018
• Est. Priority Date: 06/28/2013
• Status: Active Grant

• Current Assignee: Lambda Nu Technology LLC
• Original Assignee: Lambda Nu Technology LLC
• Inventors: Kroll, Mark, Swerdlow, Charles, Kollmann, Daniel T.
• Primary Examiner(s): Bertram, Eric D.
• Assistant Examiner(s): So, Elizabeth K
• Application Number:
  US14/203,688
• Publication Number:
  US 20150005862A1
• Time in Patent Office: 1,701 Days
• Field of Search: 607 4, 607122
• CPC Class Codes: A61N 1/0563 specially adapted for defibrillation or cardioversion

Abstract

Scientific and medical system circuitry for diagnosis of implantable cardioverter defibrillator (ICD) lead conductor anomalies, in particular conductor migration and externalization within an ICD implantable cardiac lead. The system determines an “imaginary” component of the high frequency transmission line impedance having certain spectral changes that correspond to radially outward movements or local externalization of a conductor within a lead body allowing for the detection of conductor migration and small insulation failures.

Claims

1. A method to determine the integrity of an implantable cardiac lead implanted in a patient, comprising:

determining a length of the implantable cardiac lead;

calculating a test frequency based on the length;

using a frequency signal source to apply a set of test signals to the implantable cardiac lead at frequencies within a predetermined range of the test frequency, each test signal including a phase shifted signal;

measuring an instantaneous imaginary component of a transmission line impedance of the implantable cardiac lead in response to the each test signal;

determining an imaginary impedance for each test signal based on the imaginary component of the transmission line impedance;

comparing changes in the imaginary impedance for each test signal to a predetermined threshold to determine whether the implantable cardiac lead has a potential lead integrity issue; and

communicating an indication of the potential lead integrity issue in response to determining that the implantable cardiac lead has a potential lead integrity issue by reporting the potential lead integrity issue for the patient to a medical professional.

2. The method of claim 1 wherein the method further comprises:

extracting the implantable cardiac lead based upon determination of the potential lead integrity issue.

3. The method of claim 1 wherein:

using the frequency signal source to apply the set of test signals includes generating a high frequency signal and delivering the high frequency signal across a sampling resistor to a selected conductor in the implantable cardiac lead;

measuring the instantaneous imaginary component of the transmission line impedance includes amplifying a voltage across the sampling resistor to generate a current signal, generating a phase shifted signal from the current signal, and using an analog divider to create an instantaneous imaginary impedance value; and

determining an imaginary impedance for each test signal includes repeating the using the frequency signal source and measuring the imaginary component for each of the set of test signals at a frequency unique to that test signal and within the predetermined range of the test frequency to obtain multiple instantaneous imaginary impedance values for each test signal and averaging the multiple instantaneous imaginary impedance values as the imaginary impedance for the selected conductor for that test signal.

4. The method of claim 1 wherein the predetermined range of the test frequency is +/−

ten percent (10%) of the test frequency.

5. The method of claim 1 wherein the predetermined threshold is whether the imaginary impedance of any test signal varies by more than +/−

ninety percent (90%) from an average imaginary impedance.

6. The method of claim 1 wherein the test frequency is greater than 100 MHz.

7. The method of claim 1 wherein the test frequency is in a range between 150 to 250 MHz.

8. The method of claim 7 wherein the test frequency is in a range between 170 to 200 MHz.

9. The method of claim 7 wherein the test frequency is in a range between 190 to 220 MHz.

10. The method of claim 1, wherein the indication of the potential lead integrity issue is communicated via at least one of:

an alert signal, a periodic RF communication, or a remote communication system.